alkl
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL) |
|||
| MBS1212944-002mgYeast | MyBiosource | 0.02mg(Yeast) | 875 EUR |
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL) |
|||
| MBS1212944-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 845 EUR |
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL) |
|||
| MBS1212944-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1025 EUR |
AUTO KJDL DISTN ALKLI H2O ACID FRP |
|||
| BLFAKDI05000000000 | Borosil | 1 Unit | Ask for price |
AUTO KJDL DISTN ALKLI FRP TOUCH ATT |
|||
| BLFAKDI06000000000 | Borosil | 1 Unit | Ask for price |
ALK (L1152R), Active |
|||
| MBS516537-0005mg | MyBiosource | 0.005mg | 320 EUR |
ALK (L1152R), Active |
|||
| MBS516537-001mg | MyBiosource | 0.01mg | 390 EUR |
ALK (L1152R), Active |
|||
| MBS516537-5x001mg | MyBiosource | 5x0.01mg | 1500 EUR |
ALK (L1196M), Active |
|||
| MBS516542-0005mg | MyBiosource | 0.005mg | 320 EUR |
ALK (L1196M), Active |
|||
| MBS516542-001mg | MyBiosource | 0.01mg | 390 EUR |
ALK (L1196M), Active |
|||
| MBS516542-5x001mg | MyBiosource | 5x0.01mg | 1500 EUR |
ALK (L1196M G1202R), Active |
|||
| MBS516548-0005mg | MyBiosource | 0.005mg | 320 EUR |
ALK (L1196M G1202R), Active |
|||
| MBS516548-001mg | MyBiosource | 0.01mg | 390 EUR |
ALK (L1196M G1202R), Active |
|||
| MBS516548-5x001mg | MyBiosource | 5x0.01mg | 1500 EUR |
ALK4290 |
|||
| HY-136788 | MedChemExpress | 10 mg | 3571.48 EUR |
|
Description: ALK4290 (AKST4290) is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. |
|||
ALK4290 |
|||
| MBS5785051-10mg | MyBiosource | 10mg | 1155 EUR |
ALK4290 |
|||
| MBS5785051-5mg | MyBiosource | 5(mg | 595 EUR |
ALK4290 |
|||
| MBS5785051-5x10mg | MyBiosource | 5x10(mg | 5055 EUR |
ALK4290 |
|||
| T36620-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ALK4290 |
|||
ALK4290 |
|||
| T36620-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ALK4290 |
|||
ALK4290 |
|||
| T36620-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ALK4290 |
|||
ALK4290 |
|||
| T36620-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ALK4290 |
|||
ALK4290 |
|||
| T36620-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ALK4290 |
|||
ALK-001 |
|||
| MBS5779496-5mg | MyBiosource | 5(mg | 915 EUR |
ALK-001 |
|||
| MBS5779496-5x5mg | MyBiosource | 5x5(mg | 3970 EUR |
ALK-001 |
|||
| T29867-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ALK-001 |
|||
ALK-001 |
|||
| T29867-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ALK-001 |
|||
ALK-001 |
|||
| T29867-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ALK-001 |
|||
ALK-001 |
|||
| T29867-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ALK-001 |
|||
ALK-001 |
|||
| T29867-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ALK-001 |
|||
ALK4290 (dihydrochloride) |
|||
| HY-136788A | MedChemExpress | Get quote | Ask for price |
|
Description: ALK4290 dihydrochloride (AKST4290 dihydrochlorid) is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. |
|||
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 1mg/mL |
|||
| BNUM2766-50 | Biotium | 1uL | 396 EUR |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 0.2mg/mL |
|||
| BNUB2766-100 | Biotium | 1uL | 225 EUR |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 0.2mg/mL |
|||
| BNUB2766-500 | Biotium | 1uL | 485 EUR |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BDP 558/568 alkyne |
|||
| 558798 | MedKoo Biosciences | 5.0mg | 390 EUR |
BDP 581/591 alkyne |
|||
| 558799 | MedKoo Biosciences | 5.0mg | 390 EUR |
BDP 630/650 alkyne |
|||
| 558800 | MedKoo Biosciences | 5.0mg | 390 EUR |
BDP 650/665 alkyne |
|||
| 558801 | MedKoo Biosciences | 5.0mg | 390 EUR |
BDP 630/650 alkyne, 1 mg |
|||
| A54B0 | Lumiprobe | 1 mg | 129.6 EUR |
BDP 581/591 alkyne, 1 mg |
|||
| A64B0 | Lumiprobe | 1 mg | 129.6 EUR |
BDP 558/568 alkyne, 1 mg |
|||
| A74B0 | Lumiprobe | 1 mg | 129.6 EUR |
BDP 650/665 alkyne, 1 mg |
|||
| A84B0 | Lumiprobe | 1 mg | 129.6 EUR |
BDP 630/650 alkyne, 5 mg |
|||
| B54B0 | Lumiprobe | 5 mg | 218.4 EUR |
BDP 581/591 alkyne, 5 mg |
|||
| B64B0 | Lumiprobe | 5 mg | 218.4 EUR |
BDP 558/568 alkyne, 5 mg |
|||
| B74B0 | Lumiprobe | 5 mg | 218.4 EUR |
BDP 650/665 alkyne, 5 mg |
|||
| B84B0 | Lumiprobe | 5 mg | 218.4 EUR |
BDP 630/650 alkyne, 25 mg |
|||
| D54B0 | Lumiprobe | 25 mg | 379.2 EUR |
BDP 581/591 alkyne, 25 mg |
|||
| D64B0 | Lumiprobe | 25 mg | 379.2 EUR |
BDP 558/568 alkyne, 25 mg |
|||
| D74B0 | Lumiprobe | 25 mg | 379.2 EUR |
BDP 650/665 alkyne, 25 mg |
|||
| D84B0 | Lumiprobe | 25 mg | 379.2 EUR |
